Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
Quick Stats
Jan 30, 202652.2
AI Score
HOLD0.86
Volume Ratio
Mar 09, 2026
Next Earnings
12
+ve Days (30d)
18
-ve Days (30d)
TNYA Stock Summary
Last updated Jan 30, 2026
TNYA is currently trading at $0.7747, positioned below its 200-day moving average of $0.96, suggesting bearish momentum. The stock has a 52-week range of $0.36 to $2.35.
Technical Analysis: The 50-day moving average stands at $0.93, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 48.063, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.018, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates TNYA at 52.2/100 with a HOLD recommendation.
TNYA (Tenaya Therapeutics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 48.063 |
| CMF (20) | 0.018 |
| ROC (10) | 5.101 |
| ADX (14) | 30.518 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.048 |
| AROONOSC (14) | 14.286 |
| WILLAMS %R (14) | -23.715 |
| MFI (14) | 51.145 |
TNYA Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
TNYA Price vs Max Options Open Interest
TNYA Max Change In Options Open Interest
TNYA Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TNYA Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TNYA Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TNYA Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Tenaya Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
TNYA Moving Averages Analysis
TNYA (Tenaya Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 0.73 |
| 20 | 0.74 |
| 30 | 0.73 |
| 50 | 0.93 |
| 100 | 1.24 |
| 200 | 0.96 |
TNYA Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 171.0 million |
| Earnings/Share ($) | -0.75 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.5829 |
| EPS Estimate Next Year ($) | -0.4617 |
| WallStreet Target Price ($) | 10 |
| Most Recent Quarter |